What is the translation of " INTERIM ANALYSIS " in Slovenian?

• vmesna analiza
• vmesni analizi

Examples of using Interim analysis in English and their translations into Slovenian

Interim analysis.
Vmesna analiza.

Pre-specified interim analysis.
Vnaprej določena vmesna analiza.

An interim analysis was performed with a median follow up of 55 months.
Narejena je bila vmesna analiza z mediano 55- mesečnim spremljanjem.

Survival continued to be followed after the interim analysis.
Po vmesni analizi so še naprej spremljali preživetje.

The interim analysis for OS was conducted when 331 events were observed.
Vmesna analiza celokupnega preživetja je bila izvedena, ko je bilo zabeleženih 331 dogodkov.

The trial was stopped for futility after an interim analysis.
Preskušanje so po vmesni analizi ustavili zaradi neuspešnosti.

This interim analysis showed a TTP risk reduction of 45%(95% CI: 29-57%), p< 0.0001.
Vmesna analiza je pokazala zmanjšanje tveganja za TTP za 45%(95% IZ; od 29 do 57%), p< 0,0001.

An objective response was observed for four of six evaluable adolescent in an interim analysis of Study 5.
Objektivni odziv so ugotovili pri štirih od šestih ocenljivih mladostnikov na vmesni analizi študije 5.

An interim analysis was performed when all subjects had completed the month 48 study visit.
Vmesna analiza je bila narejena, ko so vse preiskovanke opravile obisk ob 48. mesecu študije.

CI= confidence interval a The Phase 3 study ALSYMPCA was stopped for efficacy after the interim analysis.
IZ= interval zaupanja a Študija ALSYMPCA III. faze je bila zaradi učinkovitosti po vmesni analizi ustavljena.

At an interim analysis of the on-going registry, data from 96 patients with severe VOD were available.
Pri vmesni analizi potekajočega registra so bili na voljo podatki za 96 bolnikov s hudo VOB.

The study was un-blinded after this planned interim analysis of OS had crossed the pre-specified efficacy boundary.
Študija je bila razkrita potem, ko je ta načrtovana vmesna analiza učinkovitosti celokupnega preživetja presegla vnaprej določeno mejo učinkovitosti.

In an interim analysis of the ERADICATE trial, 40 of the 50 patients had reached 12 weeks post treatment and had SVR12 rates of 98 percent(n=39/40).
Ob vmesni analizi je 40 bolnikov doseglo 12 tednov po zdravljenju in SVR12 je bil 98%(39/40).

Central laboratory drug susceptibility testing results became available for one additional placebo subject after the week 24 interim analysis.
Za enega dodatnega preiskovanca iz skupine, ki je prejemala placebo, so bili rezultati testiranja občutljivosti v centralnem laboratoriju razpoložljivi po vmesni analizi po 24 tednih.

At the time of the interim analysis 40 patients have reached 12 weeks post treatment and SVR12 was 98%(39/40).
Ob vmesni analizi je 40 bolnikov doseglo 12 tednov po zdravljenju in SVR12 je bil 98%(39/40).

The interim analysis of a recent multicentre study discussed 110 patients who underwent 1:1 randomisation to either tacrolimus or ciclosporin.
Vmesna analiza novejše multicentrične študije obravnava 110 bolnikov, ki so bili v razmerju 1: 1 randomizirani na takrolimus ali ciklosporin.

Criteria for statistical significance at the interim analysis of OS was a p-value≤ 0.00274(using Lan DeMets spending function approximating O'Brien Fleming boundary).
Ob vmesni analizi je bilo merilo za statistično značilnost razlike v skupnem preživetju vrednost p ≤ 0,00274(z uporabo funkcije Lan DeMets).

An interim analysis of RE-VERSE AD included data for 123 patients: 66 patients with serious bleeding(Group A) and 57 requiring an urgent procedure(Group B).
Vmesna analiza RE-VERSE AD je vključevala podatke 123 bolnikov: 66 bolnikov z resnimi krvavitvami(skupina A) in 57 bolnikov, ki so potrebovali nujne posege(skupina B).

Since data from the trial were included in an interim analysis, a two-sided 95.02% confidence interval applied which corresponds to a p-value of less than 0.0498 for significance.
Ker so podatke iz študije vključili v vmesno analizo, so uporabili dvostranski 95,02% interval zaupanja, kar ustreza vrednosti p s stopnjo značilnosti manj kot 0,0498.

This interim analysis showed a TTP risk reduction of 45%(95% CI; 29-57%, p< 0.0001) for patients treated with combination therapy of bortezomib and pegylated liposomal doxorubicin.
Vmesna analiza je pokazala zmanjšanje tveganja za TTP za 45%(95% IZ; od 29 do 57%, p< 0,0001) pri bolnikih, ki so prejemali kombinirano terapijo z bortezomibom in pegiliranim liposomskim doksorubicinom.

GA pre-specified interim analysis for OS was performed based on a minimum follow-up time of 35.4 months.
GVnaprej določena vmesna analiza celokupnega preživetja(OS) je bila izvedena na osnovi minimalnega časa spremljanja 35,4 meseca.

An interim analysis showed there was a significant prolongation of the time to progression of disease in the 10 mg/ kg group as compared with the placebo group(hazard ratio, 2.55; p< 0.001).
Vmesna analiza je pokazala, da je čas do napredovanja bolezni pomembno podaljšan v skupini, ki je prejemala 10 mg/ kg v primerjavi s skupino, ki je prejemala placebo(razmerje ogroženosti 2, 55; p< 0, 001).

The 180/1.3 arm was stopped after an interim analysis, as prespecified in the protocol, when the two active-treatment arms appeared to have a similar incidence of bleeding.
Krak 180/1,3 te študije so ustavili po vmesni analizi, kot je bilo vnaprej določeno v protokolu, ker je kazalo, da je incidenca krvavitev v obeh krakih z aktivnim zdravljenjem podobna.

In an interim analysis of an ongoing clinical outcome study, an independent safety monitoring committee identified a higher than expected incidence of myopathy in Chinese patients taking Pelzont and simvastatin 40 mg.
V vmesni analizi trenutno potekajoče preživetvene študije je neodvisen odbor za spremljanje varnosti odkril višjo pojavnost miopatije pri kitajskih bolnikih, ki so jemali zdravilo Pelzont in simvastatin 40 mg, kot je bilo pričakovano.

The trial was stopped after an interim analysis due to a low likelihood of demonstrating a significant difference in 28-day mortality by the end of the trial.
Preskušanje so po vmesni analizi ustavili zaradi majhne verjetnosti, da bi lahko do konca preskušanja dokazali značilno razliko 28- dnevne umrljivosti.

Lung transplantation The interim analysis of a recent multicentre study discussed 110 patients who underwent 1:1 randomisation to either tacrolimus or ciclosporin.
Presaditev pljuč Vmesna analiza novejše multicentrične študije obravnava 110 bolnikov, ki so bili v razmerju 1: 1 randomizirani na takrolimus ali ciklosporin.

Of some relevance is the interim analysis data from the ongoing case-control study of the progestogen releasing contraceptive IUD(Mirena)(ICPE meeting report, 2008).
Nekoliko ustreznejša je vmesna analiza podatkov iz študije primerov in kontrol o kontracepciji IUD, ki sprošča progestogen(Mirena)(Poročilo o srečanju ICPE, 2008).

The protocol pre-specified interim analysis after 520 deaths showed a statistically significant superiority in overall survival in patients treated with enzalutamide compared to placebo(Table 3 and Figures 4 and 5).
V protokolu vnaprej določena vmesna analiza po 520 smrtih je pri bolnikih, ki so prejemali enzalutamid, pokazala statistično značilno superiornost glede celokupnega preživetja v primerjavi s placebom(preglednica 3 in sliki 4 in 5).